Profile of bevacizumab in the treatment of platinum-resistant ovarian cancer: current perspectives

od McClung, E Clair, Wenham, Robert M
Izdano u Int J Womens Health (2016)

Implementing Personalized Medicine in a Cancer Center

od Fenstermacher, David A., Wenham, Robert M., Rollison, Dana E., Dalton, William S.
Izdano 2011

A sporadic gastric-type endocervical adenocarcinoma with endometrial involvement and bilateral ovarian metastasis, a case report

od Saglam, Ozlen, Lin, Douglas I., Steele, Christine B., Killian, Jonathan K., Wenham, Robert M.
Izdano u Gynecol Oncol Rep (2020)

New therapies for advanced, recurrent, and metastatic endometrial cancers

od Makker, Vicky, Green, Angela K., Wenham, Robert M., Mutch, David, Davidson, Brittany, Miller, David Scott
Izdano u Gynecol Oncol Res Pract (2017)

Major vascular injury during gynecologic cancer surgery

od Buras, Andrea L., Chern, Jing Yi, Chon, Hye Sook, Shahzad, Mian M., Wenham, Robert M., Hoffman, Mitchel S.
Izdano u Gynecol Oncol Rep (2021)

Lagged Relationships Among Sleep Disturbance, Fatigue, and Depressed Mood During Chemotherapy

od Jim, Heather S.L., Jacobsen, Paul B., Phillips, Kristin M., Wenham, Robert M., Roberts, William, Small, Brent J.
Izdano 2013

Phase I study of oral ridaforolimus in combination with paclitaxel and carboplatin in patients with solid tumor cancers

od Chon, Hye Sook, Kang, Sokbom, Lee, Jae K., Apte, Sachin M., Shahzad, Mian M., Williams-Elson, Irene, Wenham, Robert M.
Izdano u BMC Cancer (2017)

Right Place, Right Time: Preferences of Women with Ovarian Cancer for Delivery of CAM Education

od Ebbert, Judith Ann, Donovan, Kristine A., Lengacher, Cecile A., Fabri, Donna, Reich, Richard, Daley, Ellen, Thompson, Erika Lynne, Wenham, Robert M.
Izdano u Medicines (Basel) (2015)

Gene expression signature-based prediction of lymph node metastasis in patients with endometrioid endometrial cancer

od Kang, Sukbum, Thompson, Zachary, McClung, Emily, Abdallah, Reem, Lee, Jae K., Gonzalez-Bosquet, Jesus, Wenham, Robert M., Chon, Hye Sook
Izdano u Int J Gynecol Cancer (2018)

A phase I trial of dasatinib, a Src-family kinase Inhibitor, in combination with paclitaxel and carboplatin in patients with advanced or recurrent ovarian cancer

od Secord, Angeles Alvarez, Teoh, Deanna K., Barry, William T., Yu, Miao, Broadwater, Gloria, Havrilesky, Laura J., Lee, Paula S., Berchuck, Andrew, Lancaster, Johnathan, Wenham, Robert M.
Izdano 2012

Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer

od BOU ZGHEIB, NADIM, MARCHION, DOUGLAS C., BUSH, STEPHEN H., JUDSON, PATRICIA L., WENHAM, ROBERT M., APTE, SACHIN M., LANCASTER, JOHNATHAN M., GONZALEZ-BOSQUET, JESUS
Izdano u Oncol Lett (2016)

Illuminating the Numbers: Integrating Mathematical Models to Optimize Photomedicine Dosimetry and Combination Therapies

od Spring, Bryan Q., Lang, Ryan T., Kercher, Eric M., Rizvi, Imran, Wenham, Robert M., Conejo-Garcia, José R., Hasan, Tayyaba, Gatenby, Robert A., Enderling, Heiko
Izdano u Front Phys (2019)

ERBB4 Expression in Ovarian Serous Carcinoma Resistant to Platinum-Based Therapy

od Saglam, Ozlen, Xiong, Yin, Marchion, Douglas C., Strosberg, Carolina, Wenham, Robert M., Johnson, Joseph J., Saeed-Vafa, Daryoush, Cubitt, Christopher, Hakam, Ardeshir, Magliocco, Anthony M.
Izdano u Cancer Control (2017)

Grade-specific prostate cancer associations of IGF1 (CA)19 repeats and IGFBP3-202A/C in blacks and whites.

od Hoyo, Cathrine, Grubber, Janet, Demark-Wahnefried, Wendy, Marks, Jeffrey R., Freedland, Stephen J., Jeffreys, Amy S., Grambow, Steven C., Wenham, Robert M., Walther, Philip J., Schildkraut, Joellen M.
Izdano 2007

Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors conta...

od Garrett, Christopher R., Coppola, Domenico, Wenham, Robert M., Cubitt, Christopher L., Neuger, Anthony M., Frost, Timothy J., Lush, Richard M., Sullivan, Daniel M., Cheng, Jin Q., Sebti, Saïd M.
Izdano u Invest New Drugs (2010)

MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53/Nanog

od Xu, Cheng-Xiong, Xu, Meng, Tan, Lei, Yang, Hua, Permuth-Wey, Jennifer, Kruk, Patricia A., Wenham, Robert M., Nicosia, Santo V., Lancaster, Johnathan M., Sellers, Thomas A., Cheng, Jin Q.
Izdano 2012

MicroRNA MiR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog.

od Xu, Cheng-Xiong, Xu, Meng, Tan, Lei, Yang, Hua, Permuth-Wey, Jennifer, Kruk, Patricia A., Wenham, Robert M., Nicosia, Santo V., Lancaster, Johnathan M., Sellers, Thomas A., Cheng, Jin Q.
Izdano u J Biol Chem (2016)

Utilizing the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated with Adjuvant Radiotherapy

od Mohammadi, Homan, Prince, Austin, Figura, Nicholas B., Peacock, Jeffrey S., Fernandez, Daniel C., Montejo, Michael E., Chon, Hye Sook, Wenham, Robert M., Eschrich, Steven A., Torres-Roca, Javier F., Ahmed, Kamran A.
Izdano u Int J Radiat Oncol Biol Phys (2019)

“I think that a brief conversation from their provider can go a very long way”: Patient and provider perspectives on barriers and facilitators of genetic testing after ovarian canc...

od Mallen, Adrianne R., Conley, Claire C., Fuzzell, Lindsay, Ketcher, Dana, Augusto, Bianca M., McIntyre, McKenzie, Barton, Laura V., Townsend, Mary K., Fridley, Brooke L., Tworoger, Shelley S., Wenham, Robert M., Vadaparampil, Susan T.
Izdano u Support Care Cancer (2020)

BCL2 antagonist of cell death kinases, phosphatases, and ovarian cancer sensitivity to cisplatin

od Bansal, Nisha, Marchion, Douglas C., Bicaku, Elona, Xiong, Yin, Chen, Ning, Stickles, Xiaomang B., Sawah, Entidhar Al, Wenham, Robert M., Apte, Sachin M., Gonzalez-Bosquet, Jesus, Judson, Patricia L., Hakam, Ardeshir, Lancaster, Johnathan M.
Izdano 2012